Co-Authors
This is a "connection" page, showing publications co-authored by Brandi Freeman and Natalie Thornburg.
Connection Strength
0.695
-
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020 Jul 21.
Score: 0.223
-
A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time. Clin Infect Dis. 2021 10 05; 73(7):e1841-e1849.
Score: 0.061
-
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 in the United States. Clin Infect Dis. 2021 10 05; 73(7):1805-1813.
Score: 0.061
-
Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies. PLoS One. 2021; 16(7):e0255208.
Score: 0.060
-
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020. Clin Infect Dis. 2021 06 15; 72(12):e1004-e1009.
Score: 0.059
-
Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019-April 2020. PLoS One. 2021; 16(5):e0252235.
Score: 0.059
-
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee. Clin Infect Dis. 2021 05 04; 72(9):1645-1648.
Score: 0.059
-
Lack of Serologic Evidence of Infection Among Health Care Personnel and Other Contacts of First 2 Confirmed Patients With COVID-19 in Illinois, 2020. Public Health Rep. 2021 Jan/Feb; 136(1):88-96.
Score: 0.057
-
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020. Emerg Infect Dis. 2020 Sep; 26(9):1998-2004.
Score: 0.056